Elevation Oncology, Inc. (ELEV)
NASDAQ: ELEV · Real-Time Price · USD
0.3603
+0.0173 (5.04%)
At close: May 12, 2025, 4:00 PM
0.3425
-0.0178 (-4.94%)
After-hours: May 12, 2025, 6:18 PM EDT
Elevation Oncology Market Cap
Elevation Oncology has a market cap or net worth of $21.34 million as of May 12, 2025. Its market cap has decreased by -88.70% in one year.
Market Cap
21.34M
Enterprise Value
-40.71M
1-Year Change
-88.70%
Ranking
Category
Stock Price
$0.36
Market Cap Chart
Since the IPO on June 25, 2021, Elevation Oncology's market cap has decreased from $365.16M to $21.34M, a decrease of -94.16%. That is a compound annual growth rate of -51.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 20.31M | -38.93% |
| Dec 31, 2024 | 33.26M | 46.03% |
| Dec 29, 2023 | 22.78M | 2.97% |
| Dec 30, 2022 | 22.12M | -84.16% |
| Dec 31, 2021 | 139.65M | -61.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |